Overview
Diiodohydroxyquinoline, also known as uidoquinol and iodoquinol, is a quinoline derivative that can be used in the treatment of amoebiasis. The exact mechanism of action is unknown. Iodoquinol is not currently available in any FDA-approved products.
Indication
用于治疗或无明显症状的阿米巴痢疾,对急性阿米巴痢疾及较顽固病例宜与甲硝唑联合应用,才可达到根治效果。对肠外阿米巴病如肝脓肿无效。
Associated Conditions
- Diarrhea (Dysentery)
- Enteritis
- Gastrointestinal Tract Infections
- Infectious diarrhea
- Trichomonas Vaginalis Infection
- Vaginal Candidiasis
- Vaginal Inflammation caused by Trichomoniasis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Westminster Pharmaceuticals, LLC | 69367-286 | TOPICAL | 10 mg in 1 g | 5/12/2023 | |
Syntenza Pharmaceuticals LLC | 72056-040 | TOPICAL | 10 mg in 1 g | 5/6/2020 | |
KMM Pharmaceuticals, LLC | 52187-532 | TOPICAL | 10 mg in 1 g | 12/22/2020 | |
Sincerus Florida, LLC | 72934-2111 | TOPICAL | 1 g in 100 g | 5/16/2019 | |
Primus Pharmaceuticals | 68040-706 | TOPICAL | 12.5 mg in 1 g | 10/7/2009 | |
KMM Pharmaceuticals, LLC | 52187-545 | TOPICAL | 10 mg in 1 g | 2/18/2021 | |
Primus Pharmaceuticals | 68040-705 | TOPICAL | 10 mg in 1 g | 10/30/2009 | |
Syntenza Pharmaceuticals LLC | 72056-020 | TOPICAL | 10 mg in 1 g | 5/6/2020 | |
KMM Pharmaceuticals, LLC | 52187-551 | TOPICAL | 10 mg in 1 g | 2/28/2022 | |
Artesa Labs, LLC | 57893-302 | TOPICAL | 10 mg in 1 g | 9/7/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
FLORAQUIN Pessraies | 33329 | Proqualix Pty Ltd - in Administration | Medicine | A | 10/29/1991 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
OVOQUINOL CONES | lab nadeau ltée, division of technilab inc. | 00522074 | Suppository - Vaginal | 75 MG / SUP | 12/31/1963 |
DIODOQUIN TAB 210MG | glenwood laboratories canada ltd. | 01997769 | Tablet - Oral | 210 MG | 12/31/1992 |
OVOQUINOL CRM VAGINALE | lab nadeau ltée, division of technilab inc. | 00464651 | Cream - Vaginal | 2 % | 12/31/1980 |
DIODOQUIN TAB 650MG | glenwood laboratories canada ltd. | 01997750 | Tablet - Oral | 650 MG | 12/31/1992 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.